Biosimilars: A revolution for biologics in the pharmaceutical industry
This project report is submitted in partial fulfilment of the requirements for the degree of Bachelor of Pharmacy, 2017.
Autore principale: | Moreino, Shannon Sherwin |
---|---|
Altri autori: | Kabir, Eva Rahman |
Natura: | Project report |
Lingua: | English |
Pubblicazione: |
BRAC University
2018
|
Soggetti: | |
Accesso online: | http://hdl.handle.net/10361/9331 |
Documenti analoghi
-
Biologics and Biosimilars as Treatment Options for Psoriasis
di: Moya, Amena Khatun
Pubblicazione: (2023) -
Biosimilar in lymphoma treatment
di: Tanisha, Mehrin Haque
Pubblicazione: (2021) -
Biosimilar insulins: a potential option in the treatment of Diabetes
di: Tabassum, Turana
Pubblicazione: (2022) -
Concepts and challenges of biosimilars to mitigate the oncology drug expenses
di: Tania, Umme
Pubblicazione: (2021) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
di: Tania, Umme
Pubblicazione: (2023)